PI3K

Phosphoinositide 3-kinases (PI3Ks) are lipid kinases that catalyze the phosphorylation of phosphatidylinositol 4,5-bisphosphate (PI(4,5)P₂) to generate the second messenger phosphatidylinositol (3,4,5)-trisphosphate (PI(3,4,5)P₃). The production of PI(3,4,5)P₃ facilitates the recruitment and activation of pleckstrin homology (PH) domain–containing proteins at the plasma membrane, thereby initiating downstream signaling cascades essential for cellular proliferation, survival, and migration.

PI3Ks are divided into three major classes, among which Class I PI3Ks are most prominently implicated in cancer biology. Class I enzymes comprise four distinct catalytic isoforms: PI3Kα, PI3Kβ, PI3Kδ, and PI3Kγ.

Class IA PI3Ks, the subclass most commonly associated with oncogenic signaling, function as heterodimeric lipid kinases composed of a catalytic p110 subunit (p110α, p110β, or p110δ, encoded by PIK3CA, PIK3CB, and PIK3CD, respectively) and a regulatory p85 subunit.

The PI3K signaling pathway plays a central role in diverse biological processes, including cell cycle progression, cellular growth, survival, actin cytoskeletal rearrangement, migration, and intracellular vesicular trafficking.

Frequently Asked Questions
Phosphoinositide 3-kinases (PI3Ks) are a family of lipid kinases that phosphorylate phosphatidylinositol lipids to regulate cell growth, survival, metabolism, and immune signaling. PI3K activation leads to downstream AKT and mTOR pathway signaling. Aberrant PI3K signaling is frequently observed in cancer due to PIK3CA mutations, PTEN loss, or receptor tyrosine kinase activation.
Class I PI3Ks include four catalytic isoforms: PI3Kα (PIK3CA) PI3Kβ (PIK3CB) PI3Kδ (PIK3CD) PI3Kγ (PIK3CG) PI3Kα and β are broadly expressed, while PI3Kδ and γ are enriched in leukocytes and play critical roles in immune regulation. Isoform selectivity is an important consideration in drug development due to toxicity and immune effects.
PI3K inhibitors can be classified as: Pan-PI3K inhibitors Isoform-selective inhibitors (α, β, δ, γ) Dual PI3K/mTOR inhibitors Irreversible inhibitors Selectivity influences therapeutic window and toxicity profile.
While PI3K inhibitors block upstream lipid kinase activity, mTOR inhibitors act downstream at the level of mTORC1 or mTORC2. Dual PI3K/mTOR inhibitors target both nodes of the pathway and may achieve broader pathway suppression.

Items 376-400 of 411

  • PI3Kβ-IN-1
    Cat. No.
    A79868

    PI3Kβ-IN-1

    PI3Kβ-IN-1 is a selective inhibitor of phosphoinositide 3-kinase beta (PI3Kβ) with an IC50 value of 2 nM, demonstrating potent activity against this target. This compound is suitable for in vitro and in vivo research applications aimed at investigating the role of PI3Kβ in various signaling pathways and disease models, including cancer and metabolic disorders. Its oral bioavailability enhances its potential for therapeutic development and translational studies.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • PI3Kγ inhibitor 5
    Cat. No.
    A79869

    PI3Kγ inhibitor 5

    PI3Kγ inhibitor 5 is a selective inhibitor of phosphoinositide 3-kinase γ (PI3Kγ), exhibiting an IC50 value of 34 nM. This compound is vital for studying the role of PI3Kγ in cellular signaling pathways, including immune response and cancer progression. It serves as a valuable tool in research focused on targeting PI3K signaling in various disease models.

    5 mg
    $795.00
    All 1 sizes
  • IHMT-PI3K-455
    Cat. No.
    A79870

    IHMT-PI3K-455

    IHMT-PI3K-455 is a selective, orally active dual inhibitor of PI3Kγ and PI3Kδ, exhibiting IC50 values of 7.1 nM and 0.57 nM for each isoform, respectively. This compound effectively suppresses AKT phosphorylation, leading to documented inhibition of tumor growth through the recruitment and activation of CD8+ cytotoxic T cells. IHMT-PI3K-455 is primarily utilized in cancer research to explore its therapeutic potential and mechanisms in tumor biology.

    Out of stock

    All 3 sizes
  • RV-1729
    Cat. No.
    A79871

    RV-1729

    RV-1729 is a potent inhibitor of phosphatidylinositol 3-kinase-delta (PI3Kδ), with an IC50 value of 12 nM for the release of phosphatidylinositol 3,4,5-triphosphate (PIP3). This compound exhibits significant selectivity, being twice as selective for PI3Kδ compared to PI3Kγ and 16 times more selective for PI3Kα. RV-1729 modulates immune and inflammatory responses, making it a valuable tool in research applications related to asthma and chronic obstructive pulmonary disease (COPD).

    25 mg
    $1,405.00
    50 mg
    $1,790.00
    All 3 sizes
  • PI3K/PIKK-IN-2
    Cat. No.
    A79872

    PI3K/PIKK-IN-2

    PI3K/PIKK-IN-2 is a potent inhibitor of the phosphoinositide 3-kinase (PI3K) and phosphoinositide-dependent kinase (PIKK) pathways. This compound demonstrates significant biological activity by modulating signaling pathways involved in cell growth, metabolism, and survival. PI3K/PIKK-IN-2 is suitable for use in research applications focused on targeted therapies, including the development of antibody-drug conjugates (ADCs).

    Out of stock

    All 3 sizes
  • Nemiralisib succinate
    Cat. No.
    A79873

    Nemiralisib succinate

    Synonyms: GSK2269557 succinate

    Nemiralisib succinate is a potent and selective inhibitor of phosphoinositide 3-kinase delta (PI3Kδ), exhibiting a pKi of 9.9. This compound demonstrates significant anti-inflammatory effects and is utilized in research applications focusing on immune response modulation and cancer therapy. Its specificity for PI3Kδ makes it an important tool for investigating pathways involved in various diseases, particularly those associated with hematological malignancies and autoimmune disorders.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • PI3Kδ-IN-13
    Cat. No.
    A79874

    PI3Kδ-IN-13

    PI3Kδ-IN-13 is a selective inhibitor of phosphoinositide 3-kinase delta (PI3Kδ) with an IC50 of 2.6 nM. This compound demonstrates significant activity in modulating cell proliferation and has potential applications in researching various diseases, including cancer, infections, inflammation, and autoimmune disorders. Its specificity towards PI3Kδ makes it a valuable tool for dissecting the biological pathways involved in these conditions.

    Out of stock

    All 3 sizes
  • PI3K-IN-19 hydrochloride
    Cat. No.
    A79875

    PI3K-IN-19 hydrochloride

    PI3K-IN-19 hydrochloride is a potent inhibitor of phosphatidylinositol-3-kinase (PI3K), targeting the PI3K signaling pathway involved in cellular growth and survival. This compound demonstrates significant biological activity in modulating PI3K-mediated processes, making it valuable for studying cancer and metabolic disorders. Its application extends to research on drug development and mechanistic studies of PI3K-related pathways.

    5 mg
    $795.00
    All 1 sizes
  • PI3Kδ-IN-18
    Cat. No.
    A79876

    PI3Kδ-IN-18

    PI3Kδ-IN-18 is a highly selective inhibitor of the phosphoinositide 3-kinase delta (PI3Kδ) with an IC50 value below 0.1 nM. This compound demonstrates potent inhibitory activity, making it a valuable tool for research applications focused on autoimmune diseases and related signaling pathways. Its ability to modulate PI3Kδ activity allows for the exploration of therapeutic strategies targeting immune cell functionality and inflammation.

    Out of stock

    All 3 sizes
  • Hit20
    Cat. No.
    A79877

    Hit20

    Hit20 is a selective inhibitor of PI3Kα, effectively inhibiting PI3Kα kinase activity and reducing phosphorylation of this target. This compound demonstrates significant biological activity by suppressing proliferation, colony formation, migration, and invasion in colon cancer cells. Hit20 is a valuable tool for investigating the role of PI3Kα in colon cancer research and therapeutic development.

    Out of stock

    All 3 sizes
  • PI3Kα-IN-15
    Cat. No.
    A79878

    PI3Kα-IN-15

    PI3Kα-IN-15 is a highly selective inhibitor of the phosphoinositide 3-kinase alpha (PI3Kα) with an IC50 of 0.15 μM. It demonstrates significant anti-proliferative effects against various cancer cell lines, including SKOV-3, T47D, NCI-H1975, NCI-H460, and MCF-7, with IC50 values of 26.6 μM, 7.9 μM, 32.1 μM, 17.7 μM, and 9.4 μM, respectively. PI3Kα-IN-15 is valuable for investigations into cancer biology and potential therapeutic strategies targeting the PI3K pathway.

    Out of stock

    All 3 sizes
  • PI3K-IN-60
    Cat. No.
    A79879

    PI3K-IN-60

    PI3K-IN-60 is a highly selective inhibitor targeting phosphatidylinositol 3-kinase gamma (PI3Kγ). This compound demonstrates significant biological activity in modulating immune responses and exhibits potential applications in the study of autoimmune diseases, such as multiple sclerosis, as well as various cancer types including breast cancer and pancreatic ductal adenocarcinoma.

    1 mg
    $25.00
    5 mg
    $90.00
    All 6 sizes
  • CXJ-2
    Cat. No.
    A79880

    CXJ-2

    CXJ-2 is a cyclic peptide that serves as a potent inhibitor of the PI3K/ERK signaling pathway. It significantly reduces the proliferation and migration of hepatic stellate cells, demonstrating strong antifibrotic properties. This compound is valuable for research in fibrosis and related hepatic disorders, providing insights into cellular processes influenced by the PI3K/ERK pathway.

    Out of stock

    All 3 sizes
  • PI3K-IN-12
    Cat. No.
    A79881

    PI3K-IN-12

    PI3K-IN-12 is a potent inhibitor of phosphoinositide 3-kinase (PI3K) with a primary mechanism of disrupting PI3K signaling pathways. It demonstrates significant biological activity in modulating cell survival and proliferation, making it a valuable tool for cancer research and studies investigating metabolic disorders. Researchers can utilize PI3K-IN-12 to explore the role of PI3K in various cellular processes and therapeutic interventions.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • PI3Kα-IN-20
    Cat. No.
    A79882

    PI3Kα-IN-20

    PI3Kα-IN-20 is a selective inhibitor of phosphoinositide 3-kinase alpha (PI3Kα). It effectively disrupts the PI3K signaling pathway, leading to the modulation of cellular functions such as growth, proliferation, and survival. This compound is valuable for research applications focused on cancer biology, metabolic disorders, and other conditions associated with aberrant PI3Kα activity.

    Out of stock

    All 3 sizes
  • PI3Kδ/γ-IN-2
    Cat. No.
    A79883

    PI3Kδ/γ-IN-2

    PI3Kδ/γ-IN-2 is a potent dual inhibitor of phosphoinositide 3-kinase delta (PI3Kδ) and gamma (PI3Kγ), demonstrating IC50 values of 1 nM and 4.3 nM, respectively. With favorable oral bioavailability, this compound shows promise in the treatment of B-cell malignancies, making it a valuable tool for research in cancer biology and therapeutic development targeting the PI3K signaling pathway.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • PI3K-IN-26
    Cat. No.
    A79886

    PI3K-IN-26

    PI3K-IN-26 is a potent inhibitor of phosphoinositide 3-kinase (PI3K), exhibiting an IC50 of 36 nM in SU-DHL-6 cells. This compound is useful in research focused on the PI3K signaling pathway, which plays a critical role in cell growth, proliferation, and survival. The inhibition of PI3K by PI3K-IN-26 allows for the investigation of its effects on cancer cell metabolism and identification of potential therapeutic targets.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • PI3K-IN-10
    Cat. No.
    A79887

    PI3K-IN-10

    PI3K-IN-10 is a potent pan-PI3K inhibitor derived from benzimidazole. This compound selectively targets the phosphoinositide 3-kinase (PI3K) pathway, demonstrating significant inhibitory activity across various PI3K isoforms. Its key biological activity makes it a valuable tool for investigating PI3K-related signaling mechanisms and potential therapeutic applications in cancer and metabolic disorders.

    Out of stock

    All 3 sizes
  • PI3Kδ-IN-23
    Cat. No.
    A79888

    PI3Kδ-IN-23

    PI3Kδ-IN-23 is a highly selective inhibitor of the PI3Kδ isoform, exhibiting an exceptional binding affinity with an IC50 value of 0.27 nM. This compound forms covalent bonds with the Lys779 residue on PI3Kδ, effectively blocking its activity. Its potent inhibition profile makes PI3Kδ-IN-23 a valuable tool for cancer research, particularly in studies focused on therapeutic strategies targeting PI3K signaling pathways.

    Out of stock

    All 3 sizes
  • PI3Kα-IN-1
    Cat. No.
    A79890

    PI3Kα-IN-1

    PI3Kα-IN-1 is a potent inhibitor of the phosphoinositide 3-kinase alpha (PI3Kα) with an IC50 value of less than 0.5 nM. Additionally, it exhibits inhibitory activity against mTOR with an IC50 of 104 nM. This compound is valuable for studying the PI3K/mTOR signaling pathway, which is implicated in various diseases, including cancer and metabolic disorders. Research applications include evaluating the effects of PI3Kα inhibition on cell proliferation, survival, and signaling.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • PI3Kδ-IN-26
    Cat. No.
    A79891

    PI3Kδ-IN-26

    PI3Kδ-IN-26 is a selective and orally active inhibitor of the PI3Kδ isoform, exhibiting an IC50 of 14 nM. This compound has demonstrated significant efficacy in attenuating inflammatory responses in house dust mite-induced chronic asthma models in mice. Due to its potent anti-inflammatory properties, PI3Kδ-IN-26 is a valuable tool for research into inflammatory, autoimmune, and hyperproliferative diseases.

    Out of stock

    All 3 sizes
  • LTURM 36
    Cat. No.
    A79892

    LTURM 36

    LTURM 36 is a potent inhibitor of phosphoinositide 3-kinase (PI3K), exhibiting IC50 values of 0.64 μM for PI3Kδ and 5.0 μM for PI3Kβ. This compound serves as a valuable tool in cancer research by modulating PI3K signaling pathways, which are frequently implicated in tumorigenesis and cancer progression. Its selective inhibition profile positions LTURM 36 as an important reagent for studying the roles of PI3K isoforms in various cancer types.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • PI3Kα-IN-24
    Cat. No.
    A79893

    PI3Kα-IN-24

    PI3Kα-IN-24 is a potent inhibitor of PI3Kα, exhibiting an IC50 of 0.025 μM. This compound effectively suppresses phosphorylated Akt at serine 473, demonstrating significant impact in cellular signaling pathways. It is a valuable tool for cancer research, allowing for the exploration of PI3Kα-mediated mechanisms and therapeutic strategies.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • PI3Kα-IN-17
    Cat. No.
    A79894

    PI3Kα-IN-17

    PI3Kα-IN-17 is a selective inhibitor of phosphoinositide 3-kinase alpha (PI3Kα), a critical enzyme in the PI3K signaling pathway. This compound demonstrates potent inhibitory activity, making it valuable for research focused on cancer biology and other diseases linked to dysregulated PI3Kα activity. It can be utilized to explore the role of PI3Kα in cancer cell proliferation, survival, and metabolism.

    Out of stock

    All 3 sizes
  • PI(3,4)P2 (18:1) (ammonium salt)
    Cat. No.
    A79895

    PI(3,4)P2 (18:1) (ammonium salt)

    PI(3,4)P2 (18:1) ammonium salt is a potent activator of phosphatidylinositol 3-kinase (PI3K). This polyphosphorylated phosphatidylinositol effectively promotes the activation of AKT (protein kinase B), thereby influencing key cellular processes such as metabolism, growth, and survival. Additionally, PI(3,4)P2 (18:1) ammonium salt plays a crucial role in regulating cytoskeletal dynamics, impacting cell morphology and movement. It is applicable in studies related to cancer, diabetes, and cardiovascular disease.

    0.1 mg
    $415.00
    All 1 sizes

Items 376-400 of 411

Added to your cart

View Cart Checkout

    Loading...